In short. Generation numbers, feel, warranty language and study claims: what each phrase commits the maker to, and what it leaves out.
Key points
- A sentence that explains what a feature is for is a design claim.
- A sentence that names an outcome and a comparison is a study claim.
- The first tells you a manufacturer had a reason; the second tells you somebody measured something.
Implant marketing uses a small set of phrases, and each commits the writer to a different amount. Sorting them by what they would have to demonstrate if challenged makes the whole category easier to read.
Generation numbers and sequence words
Latest, newest, fifth generation, next generation. These describe a position in a manufacturer’s own sequence. There is no regulatory category corresponding to them, and no study has established that a later position in a sequence produces a better result. They are useful for identifying a product and useless for evaluating one.
Feel and naturalness
Feels natural, softer, more anatomical. Feel is a real property of a material and it is also a judgement made by a hand rather than a measure. Natural is a comparison against an unstated standard. Neither phrase can be checked, and both are doing the work that a measured outcome would do if one existed.
Warranty language
A warranty states what a manufacturer will replace and under what conditions. It is a commercial term written by the party that sets the terms, and reading it as a durability finding mistakes a contract for evidence. It is worth reading for what it actually promises, which is usually a replacement device rather than an outcome.
A purpose is not an outcome
A sentence that explains what a feature is for is a design claim. A sentence that names an outcome and a comparison is a study claim. The first tells you a manufacturer had a reason; the second tells you somebody measured something. Only the second can be checked, and the first is far more common.
Study claims
Where a study is cited, three things decide what it is worth. What outcome was measured, and whether it is the outcome the sentence is about. How long people were followed, since capsule tightening and rupture appear over years. And who funded the work, because comparative implant studies are frequently funded by a manufacturer. A study reporting a material property in a laboratory is a real study and it is not a clinical result.
What the labelling says instead
The label is the one document about a device that had to satisfy a regulator, and it states that the implant is not a lifetime device and that rupture and contracture are recognised risks. Reading the label alongside the brochure is the fastest way to see which claims are conditions of sale and which are copy.
Three questions that sort a technology claim
- Is this a purpose, an outcome, or a position in a product sequence?
- If a study is cited, what did it measure, over how long, and who paid for it?
- What does the current labelling state about this same feature?
Most technology claims resolve into one of two groups: a description of a design choice, or a statement the labelling already answers differently. Both are worth knowing which one you are reading.
Frequently asked questions
What does a generation number tell me?
It tells you where a product sits in a manufacturer's own sequence. It is not a regulatory category, and it is not a measure of quality, so a device described as newer has not thereby been shown to be better. The number is a marketing convention rather than a finding.
Is a warranty a statement about durability?
No. A warranty states what a manufacturer will replace and under which conditions, and it is written by the party that sets the terms. It is a commercial document and not evidence about how long a device lasts in a person.
How can I tell a study claim from a design claim?
A study claim names an outcome and a comparison: fewer of something, measured over a period, against a group. A design claim describes what a feature is for. If the sentence explains a purpose without naming an outcome, it is a design claim, however confident it sounds.
Risks & Limitations
- No generation of implant is a lifetime device, and a proportion will need removal or replacement at some point.
- Rougher surfaces carry an established association with a rare lymphoma of the tissue around the implant.
- Rupture can occur without symptoms, so surveillance over time is advised whatever device is in place.
- Capsular contracture is a recognised risk and no surface has eliminated it.
- A design feature is a modification with a reason behind it, not a demonstrated improvement in outcome.
When to Seek Care
- A change in the shape or size of a breast, or a new lump — have it assessed by a clinician.
- Swelling that comes and goes, or a fluid collection around an implant.
- Persistent pain or firmness around an implant, or a new and persistent symptom.
- Contact the service that holds your records, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — approved breast implant labelling and safety communications
- European Medicines Agency (EMA) and national regulators — breast implant assessment reports and restrictions
- National Medical Products Administration (NMPA, China) — approved devices and their indications
- World Health Organization (WHO) — classification of tumours of the breast, including implant-associated lymphoma
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.